BIOCHEMICAL SOCIETY TRANSACTIONS in the serum before addition of the iron or indium, however, after addition of the metal ions the transferrins migrated as a single fast-moving species.
A number of electrophoretic variants of human serum transferrin are known; however, there is only one report of a variant with unusual physicochemical and functional properties (Evans et d., 1982) . This variant came to light, during the screening of S O 0 0 serum samples, as a result of the inability of the diferric protein to retain iron in the Cterminal site upon polyacrylamide-gel electrophoresis in the presence of 6 M-urea. When bound t o the C-terminal site the iron displays unusual visible and e.p.r. spectra. Although normal transferrin is able to bind a variety of metal ions, including Cu(ll), Zn(l1) and AI(I11), at both its sites, Cu(ll), Zn( II) and AI(II1) appear to bind at just one site in the variant (Evans et ul., 1984) . T h e iron-free C-terminal domain has also been found to be less stable than normal to both thermal and urea denaturation. In addition, studies on the interaction of the diferric variant with the transferrin receptor on phytohaemagglutinin-stimulated lymphocytes have shown that it binds with a 10-fold lower affinity than normal diferric transferrin, similar to those for the normal monoferric transferrim (Young et ul., 1984) . A s the X-ray crystallographic structures of diferric human lactoferrin and diferric rabbit serum transferrin have recently been reported at a resolution of 0.32 nm (Anderson et ul., lY87) and 0.33 nm (Bailey et ul., 1988) . respectively, it might be possible to begin to explain the unusual properties of the variant transferrin once the structural change in the protein has been identified. In this cornmunication we report the characterization of the amino acid substitution in the abnormal transferrin.
Transferrin was isolated from the plasma of the heterozygous individual by immunoaffinity chromatography (Evans et ul., lY82) and the normal and variant transfcrrins scparated by ion-exchange chromatography. T h e iron-free proteins were cleaved with cyanogen bromide and the digests analysed, under reducing conditions, by polyacrylamide-gel electrophoresis in the presence of Triton X-1 OO/acetic acid/ urea. T h e electrophoretograms were identical apart from one region where a fragment in the digest of the normal transferrin was replaced by a fragment with a higher mobility in the digest of the variant protein.
After fractionation of the cyanogen bromide digests by gel filtration further analysis on Triton X-1 OO/acetic acid/urea gels indicated that the abnormal fragment resided in cyanogcn bromide fragment CN-A (MacGillivray et ul., I Y83). CN-A from normal and variant transfcrrins was reduced, carboxyamidomethylated and fractionatcd by reverse-phase chromatography. Analysis o f fractions by both SDS/polyacrylamide-gel electrophoresis and Triton X-I OO/acetic acid/urea/polyacrylamide-gel electrophoresis showed that the abnormal fragment corresponded t o fragment CN-3 (MacGillivray et ul., 1983) comprising residues 390-464.
T h e amino acid sequence of the first 42 residues of CN-3 from the normal transferrin was determined by automatic sequencing and agreed with the published sequence (MacGillivray et ul., 1983) . T h e sequence of CN-3 from the variant transferrin was found t o be identical except at the fifth position, where a glycinc residue at position 3Y4 in thc normal protein had been replaced by an arginiile residue. A s the cDNA nucleotide sequence for thc glycine at position 394 is known to he G-G-G (Yang CI (11.. 1Y84) the subhtitution in the variant can be explained in terms of a mutational transition G -A o r G-C in the first nucleotide of the codon.
T h e recent results of X-ray crystallographic studies on human lactoferrin (Anderson et (11.. lY87) and rabbit serum transferrin (Bailey e l ul., 1988) have revealed that iron interacts with the side-chains from two tyrosine residues. one histidine residue and one aspartic acid residue. Although X-ray crystallographic studies on human serum transferrin are only at an early stage (DeLucas et d., 1978) it is anticipated that the same residues will be liganded to the iron atoms. T h e aspartic acid residue at 392 in human serum transferrin is therefore expected t o be bound to the iron in the <'-terminal domain. In the variant human serum transferrin it is likely that the positively charged arginine residue at position 394 could interact with the negatively chargcd aspartic acid residue at position 392 and prevent the normal binding of the aspartic acid t o the iron. Support for this idea comes from the observation that the visible and e.p.r. spectra of a low-molecular-mass iron-binding fragment isolated from duck ovotransferrin are very similar t o those o f the human transferrin variant (Evans & Madden. 1 Y84). From the Nterminal sequence of this fragment (R. W. Evans, unpublished work) we know that the aspartic acid is missing from the iron-binding site yet it is still able t o bind iron.
Although we are now able t o put forward an explanation for the unusual spectral properties o f the variant transferrin, an explanation of how the substitution affects both the reccp-626th MEETING, SHEFFIELD tor-binding site and the stability of the iron-free C-terminal domain must await further studies on the three-dimensional structures of the transferrins.
M' e are grateful for the continued co-operation of Miss P.C. without which this work would not have been possible. This work was supported by grants from the Special Trustees' Grant for Medical Research of Guy's Hospital. We thank Mr Andrew Macpherson for his continued technical support. The technical assistance of Alan Hams and Fatima Beg in running the protein sequencer is greatly appreciated.
The traditional approach t o the design of clinical chelating and affinity constant determinations, which, in the absence of reliable methods for screening compounds before synthesis, laboratory we are aiming to rationalize this procedure. with the aid of computer-based molecular modelling techniques. T h e strategy involves using the wealth of data already available on metal-ion complexes, first to facilitate 'knowledgebased' predictions of the 3-dimensional structures of novel complexes, and secondly to derive correlations between structure and metal-ion affinity. Here. we report the results of preliminary studies on catecholate. EDTA. hydroxamatc and acetoacetate complexes.
Systematic studies of metal-oxygen bond lengths h a w been performed using the crystal co-ordinates of complexes obtained from the Cambridge structural database (Allen ei plexes of catecholate, hydroxamate and acetoacetate, the metal-oxygen bond lengths are linearly related to metal ionic radii (with K = 0.998). These data are invaluable for modelling complexes with unknown 3-dimensional structures. since they permit reliable predictions of the appropriate Complementary studies of the metal-ion affinities of the chelators show that their log K , values are inversely correlated with the metal ionic radii. This is true for both bidentate (catecholate) and oligodentate ( E D T A ) ligands. In the case of catecholate complexes, the same relationship holds for both M3 Explanations o f these effects are obtained by considering how the conformations of the complexes are influenced by the Dreferred metal co-ordination reometrv.
L.
For EDTA complexes, the metal-ion affinities are correlated with the nitrogen ligand bite angle, NMN (Fig. 1 l i ) . This angle is generally smaller for larger cations, s o that there is a significant distortion of the octahedral geometry. This results
